ARCHIVES

FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

ODAC Chairman: Time Was Tight For Meeting

November 10, 1995

St. Jude, Washington University Plan $65 Million Pediatric Cancer Genome Project

January 29, 2010

Kennedy Agrees To Drop Dollar Limit In New Cancer Bill

January 11, 1980

Concepts for New, Recompeted DCCP Contracts Approved

June 12, 1981

After Aggressive Budgetary Trimming, At $33 Million NCI’s caBIG Remains Big

December 2, 2011

Group trials need prioritization, review, NCI official says.

July 25, 2003